Overview Fundamentals API Earnings EOD API Sample Code Pricing

Krystal Biotech Inc (KRYS NASDAQ) stock market data APIs

$206.21 -1.09(-0.5%) as of July 17, 2024
Price chart is built with Anychart

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Krystal Biotech Inc Financial Data Overview

5 920 M
28 558 K
95 949 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KRYS',
Type: 'Common Stock',
Name: 'Krystal Biotech Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00HDGRHH7',
CIK: '1711279',
EmployerIdNumber: '82-2908297',
FiscalYearEnd: 'December',
IPODate: '2017-09-20',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Krystal Biotech Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 95 949 K
  • EBITDA -50 614 000
  • Earnings Per Share 2.19
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Krystal Biotech Inc Earnings via APIs

  • Latest Release 2024-05-06
  • EPS/Forecast 0.15

Get Krystal Biotech Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?